& Johnson Development Corp Et Al Johnson is 10% at AQUINOX PHARMACEUTICALS, INC (AQXP). They have made 5 open-market trades across 2 companies since 2010, most recently 2014-12-05.
CIK 0000924020
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.0M since 2010, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AQXP | SELL | 2014-12-03 | 2014-12-05 | $7.76 | $123K | -35.3% | -0.6% | -0.6% |
| AQXP | SELL | 2014-12-01 | 2014-12-03 | $7.54 | $9K | -35.3% | -0.6% | -0.6% |
| AQXP | SELL | 2014-11-25 | 2014-11-26 | $7.75 | $16K | -35.3% | -0.6% | -0.6% |
| AQXP | SELL | 2014-11-20 | 2014-11-24 | $8.14 | $77K | -35.3% | -0.6% | -0.6% |
| TNGN | BUY | 2010-04-14 | 2010-04-14 | $5.00 | $2.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.